Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-14 Sale |
2022-12-16 7:36 pm |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
50,000 | $11.19 | $559,500 | 1,443,364 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-05 5:59 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,084 | $10.73 | $22,361 | 313,520 (Direct) |
View |
| 2022-11-22 Sale |
2022-11-23 6:57 pm |
Theravance Biopharma Inc. | TBPH | O'Connor Donal Director |
10,000 | $10.5 | $105,000 | 43,886 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-22 4:07 pm |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
65,000 | $11.02 | $716,242 | 384,714 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 6:05 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
4,906 | $9.7105 | $47,640 | 364,745 (Direct) |
View |
| 2022-08-09 Sale |
2022-08-11 6:55 pm |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
15,086 | $8.79 | $132,606 | 369,651 (Direct) |
View |
| 2022-05-23 Sale |
2022-05-24 7:11 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
1,081 | $8.93 | $9,653 | 329,990 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 7:08 pm |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
2,356 | $10.16 | $23,947 | 333,271 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-13 Gift |
2022-12-16 7:36 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
9,000 | $0 | 1,443,364 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:09 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $10.85 | 1,502,364 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:07 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,057 | $10.85 | 384,714 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:04 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
27,350 | $10.85 | 315,604 (Direct) |
View |
| 2022-11-20 Tax Withholding |
2022-11-22 4:02 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
23,268 | $10.85 | 296,309 (Direct) |
View |
| 2022-11-16 Tax Withholding |
2022-11-17 7:53 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT |
2,800 | $11.2 | 342,954 (Direct) |
View |
Ownership |
2022-10-21 7:35 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Samaha Eli 10% Owner |
0 | $0 | 7,012,226 (Indirect) |
View |
Ownership |
2022-09-28 09:33 am |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Weiss Asset Management LP WEISS ANDREW M WAM GP LLC 10% Owner |
0 | $0 | 7,457,060 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
9,644,807 | $9.75 | 9,644,807 (Indirect) |
View |
| 2022-09-16 Other |
2022-09-20 4:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GSK PLC Former 10% Owner |
269,061,000 | $0 | 9,644,807 (Indirect) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 7:03 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
15,804 | $9.34 | 1,517,351 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 7:00 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,676 | $9.34 | 473,507 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 6:57 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
18,991 | $9.34 | 345,754 (Direct) |
View |
| 2022-08-19 Tax Withholding |
2022-08-23 6:54 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
10,413 | $9.34 | 319,577 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 6:56 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
20,000 | $0 | 499,183 (Direct) |
View |
| 2022-05-20 Tax Withholding |
2022-05-24 7:19 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
11,025 | $8.74 | 1,533,155 (Direct) |
View |
| 2022-05-20 Tax Withholding |
2022-05-24 7:17 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
3,365 | $8.74 | 479,183 (Direct) |
View |
| 2022-05-20 Tax Withholding |
2022-05-24 7:14 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
3,947 | $8.74 | 384,737 (Direct) |
View |
| 2022-05-20 Tax Withholding |
2022-05-24 7:11 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
2,200 | $8.74 | 329,990 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 9:34 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | YOUNG WILLIAM D Director |
37,852 | $0 | 106,010 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 9:26 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | PAKIANATHAN DEEPIKA Director |
37,852 | $0 | 55,747 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 9:18 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | O'Connor Donal Director |
37,852 | $0 | 81,886 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 9:04 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | MITCHELL DEAN J Director |
37,852 | $0 | 88,886 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 9:00 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | MALKIEL BURTON G Director |
37,852 | $0 | 134,457 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 8:54 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | BROSHY ERAN Director |
37,852 | $0 | 88,886 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 8:50 pm |
N/A 2032-04-25 |
Theravance Biopharma Inc. | TBPH | Smaldone Alsup Laurie Director |
37,852 | $0 | 72,662 (Direct) |
View |
| 2022-02-25 Option Award |
2022-03-01 7:18 pm |
N/A 2032-02-24 |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
685,000 | $0 | 2,056,867 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:38 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Winningham Rick E CHIEF EXECUTIVE OFFICER |
22,710 | $9.61 | 1,371,867 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:34 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | PITZER KENNETH R SVP, PROD STRAT & COMM PLNG |
27,299 | $9.61 | 380,123 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:29 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER |
25,973 | $9.61 | 481,285 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:25 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | GRAHAM RICHARD A SVP, DEVELOPMENT |
20,377 | $9.61 | 388,684 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:22 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS |
11,824 | $9.61 | 335,627 (Direct) |
View |
| 2022-02-18 Tax Withholding |
2022-02-23 6:18 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | BRADY ANN PRESIDENT, TBIL |
8,369 | $9.61 | 110,319 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 5:03 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | PITZER KENNETH R SVP, PROD STRAT & COMM PLNG |
52,000 | $0 | 407,422 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 7:00 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, Comm & Medical Affairs |
27,500 | $0 | 347,451 (Direct) |
View |
Ownership |
2021-12-10 6:34 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | Farnum Rhonda SVP, Comm & Medical Affairs |
0 | $0 | 469,951 (Direct) |
View |